image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.14
-5 %
$ 16 M
Market Cap
-1.5
P/E
BALANCE SHEET
81.8 M ASSETS
-12.00%
52.5 M LIABILITIES
-7.79%
29.6 M EQUITY
-18.37%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Cumberland Pharmaceuticals Inc.
image
Current Assets 35.7 M
Cash & Short-Term Investments 18.3 M
Receivables 9.76 M
Other Current Assets 7.63 M
Non-Current Assets 46.1 M
Long-Term Investments 0
PP&E 7.04 M
Other Non-Current Assets 39 M
Current Liabilities 28 M
Accounts Payable 14 M
Short-Term Debt 348 K
Other Current Liabilities 13.6 M
Non-Current Liabilities 24.5 M
Long-Term Debt 18.1 M
Other Non-Current Liabilities 6.45 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005
ASSETS
Cash & Cash Equivalents 18.3 19.8 27.0 24.8 28.2 27.9 45.4 34.5 38.2 39.9 40.9 54.3 70.6 65.9 78.7 11.8 10.8 6.3 5.5
Short Term Investments 0 0 0 0 0 8.3 4.7 15.6 14.6 14.8 14.0 16.7 0 0 0 0 0 0 0
Receivables 9.8 13.2 6.9 12.4 7.9 7.8 8.4 7.3 6.1 5.5 4.5 6.0 7.1 5.1 6.2 3.1 2.4 5.1 2.4
Inventory 4.6 9.4 8.4 10.6 8.9 27.8 6.7 5.4 4.3 5.6 5.7 6.2 5.8 7.7 4.8 1.8 0.9 0.7 0.5
Other Current Assets 3.0 3.1 6.7 2.2 5.2 3.0 3.5 2.7 4.0 5.0 3.5 4.0 3.9 2.3 3.5 1.0 0.7 0.6 93.7 K
Total Current Assets 35.7 45.9 45.7 50.0 50.2 74.9 68.7 65.5 67.1 70.8 68.7 87.2 87.3 81.0 93.2 17.7 14.8 12.6 8.6
PP&E 7.0 5.5 1.5 2.6 3.7 0.8 0.5 0.5 0.5 0.7 0.9 1.2 1.1 1.2 0.9 0.4 0.5 0.4 0.4
Intangible Assets 22.6 30.6 24.0 28.1 30.9 33.7 21.4 22.2 21.2 21.6 15.5 9.5 7.0 7.4 8.0 8.5 9.2 9.8 37 K
Goodwill 0.9 0.9 0.9 0.9 0.9 0.8 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 (0.7) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 15.5 10.0 12.5 14.9 18.9 2.5 2.5 2.1 1.9 1.8 1.3 0.6 67.8 K 0.1 0.4 3.4 2.7 25.9 K 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 81.8 92.9 84.5 96.5 104.5 112.7 93.2 93.4 91.9 95.4 87.6 98.6 95.5 92.1 103.7 31.1 28.9 26.5 10.2
LIABILITIES
Accounts Payable 14.0 10.8 9.6 13.4 10.0 11.1 9.0 8.0 2.9 3.2 2.0 2.8 1.5 2.1 5.6 3.3 1.9 3.4 1.0
Short Term Debt 0.3 0.2 1.0 3.2 0.9 0 0 0 0 0 0 0 0 2.7 9.2 1.2 3.2 1.8 0.3
Other Current Liabilities 13.6 17.6 8.7 9.1 13.2 16.7 8.7 6.8 9.5 10.5 5.5 5.3 5.1 4.4 3.8 3.1 3.0 3.5 1.7
Total Current Liabilities 28.0 28.6 19.3 25.7 24.2 27.8 17.7 14.8 12.4 13.7 7.5 8.1 6.6 9.2 18.6 7.6 8.1 8.7 3.0
Long Term Debt 18.1 20.8 15.1 16.1 20.6 20.0 9.8 4.1 1.7 0 0 5.0 4.9 5.1 10.9 5.6 0.9 3.6 0
Deferred Tax Income 0 (2.5) (3.4) 0.7 1.3 2.0 2.1 3.2 0 0 0 0 0.6 0 0 0 0 0 0
Other Liabilities 6.5 7.6 7.5 7.9 8.7 9.3 1.8 1.4 1.0 0.9 0.8 0 0.6 0 1.9 0.4 3.1 3.1 0
Total Liabilities 52.5 57.0 41.9 49.6 53.5 57.1 29.3 20.3 15.1 14.7 8.3 13.0 12.7 14.3 31.5 13.6 12.2 15.4 3.9
EQUITY
Common Stock 47.1 47.5 48.5 49.1 49.9 51.1 52.4 54.6 57.3 61.9 63.1 67.2 0 70.8 1 930.0 0 0 0 0
Retained Earnings (17.5) (11.2) (5.6) (2.1) 1.2 4.7 11.7 18.6 19.5 18.8 16.4 18.5 12.7 7.0 4.5 1.5 (3.3) (7.4) (11.8)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Equity 29.3 36.0 42.6 46.9 51.1 55.6 63.9 73.1 76.8 80.8 79.3 85.6 82.8 77.7 72.2 17.6 16.7 11.1 6.2
Total Liabilities and Equity 81.8 92.9 84.5 96.5 104.5 112.7 93.2 93.4 91.9 95.4 87.6 98.6 95.5 92.1 103.7 31.1 28.9 26.5 10.2
SHARES OUTSTANDING
Common Shares Outstanding 14.3 14.6 14.9 15.2 15.4 15.6 15.9 15.7 16.7 17.6 18.3 19.6 20.3 20.3 14.2 10.1 10.0 9.8 9.5